TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 25 filers reported holding TCR2 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $50 | +51.5% | 33,116 | 0.0% | 0.00% | – |
| Q4 2022 | $33 | -99.9% | 33,116 | -1.3% | 0.00% | – |
| Q3 2022 | $60,000 | -41.7% | 33,561 | -5.5% | 0.00% | – |
| Q2 2022 | $103,000 | -7.2% | 35,525 | -12.2% | 0.00% | – |
| Q1 2022 | $111,000 | -75.8% | 40,477 | -58.8% | 0.00% | – |
| Q4 2021 | $458,000 | +63.0% | 98,142 | +197.1% | 0.00% | – |
| Q3 2021 | $281,000 | -59.5% | 33,032 | -21.8% | 0.00% | – |
| Q2 2021 | $694,000 | -35.6% | 42,235 | -13.4% | 0.00% | -100.0% |
| Q1 2021 | $1,077,000 | +205.1% | 48,779 | +326.6% | 0.00% | – |
| Q4 2020 | $353,000 | +16.1% | 11,435 | -23.7% | 0.00% | – |
| Q3 2020 | $304,000 | +120.3% | 14,996 | +67.2% | 0.00% | – |
| Q2 2020 | $138,000 | +360.0% | 8,969 | +130.4% | 0.00% | – |
| Q1 2020 | $30,000 | -82.2% | 3,893 | -67.2% | 0.00% | – |
| Q4 2019 | $169,000 | +89.9% | 11,885 | +102.0% | 0.00% | – |
| Q3 2019 | $89,000 | +456.2% | 5,885 | +402.1% | 0.00% | – |
| Q2 2019 | $16,000 | -60.0% | 1,172 | -49.4% | 0.00% | – |
| Q1 2019 | $40,000 | – | 2,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |